Search

Dipaparkan jumlah carian 341 - 350 daripada 1549
Reports of Kidney-Related and Liver-Related Adverse Reactions after Consumption of Ganoderma (Lingshi / Reishi) Products
Untuk makluman, pihak Seksyen Farmakovigilans (NPRA) telah menerbitkan satu artikel bertajuk NPRA Updates on Reports of Kidney-Related and Liver-Related Adverse Reactions after Consumption of...
Kategori: Berita | Tarikh: 15 Jan 2021
Jemputan Unified Public Consultation (UPC): Pelaksanaan Mekanisme Harga Ubat & Kajian Cost Benefit Analysis (CBA)
Sukacita dimaklumkan bahawa Program Perkhidmatan Farmasi, Kementerian Kesihatan Malaysia (KKM) sedang mengadakan sesi penerangan secara atas talian berkaitan status terkini Mekanisme Harga Ubat dan...
Kategori: Agenda | Tarikh: 15 Jan 2021
Unified Public Consultation (UPC): Implementation of Medicines Price Mechanism & Cost-Benefit Analysis
We are pleased to inform that the Pharmaceutical Services Program, Ministry of Health Malaysia (MOH) is ​currently ​holding multiple online briefing session on the latest status of Medicines ...
Kategori: Agenda | Tarikh: 15 Jan 2021
Malaysian Orphan Medicines Guideline 2020
The Ministry of Health (MOH) Malaysia recognises the needs of the patients with rare diseases in Malaysia. Under the Malaysian National Medicines Policy (MNMP) one of the focus areas to improve on is...
Kategori: Dokumen | Tarikh: 14 Apr 2022
Garis Panduan Ubat Orphan 2020
Kementerian Kesihatan Malaysia (KKM) mengambil berat keperluan pesakit dengan Penyakit Jarang Jumpa di Malaysia. Salah satu bidang tumpuan di bawah Dasar Ubat Nasional (DUNas) adalah untuk...
Kategori: Dokumen | Tarikh: 14 Apr 2022
Invitation to Engagement Sessions on Medicines Price Mechanism and Cost Benefit Analysis (CBA)
Sukacita dimaklumkan bahawa Program Perkhidmatan Farmasi, Kementerian Kesihatan Malaysia (KKM) akan mengadakan sesi penerangan secara atas talian berkaitan status terkini Mekanisme Harga Ubat dan...
Kategori: Agenda | Tarikh: 24 Dec 2020
Jemputan Sesi Penerangan Mekanisme Harga Ubat dan Kajian Cost Benefit Analysis (CBA)
Sukacita dimaklumkan bahawa Program Perkhidmatan Farmasi, Kementerian Kesihatan Malaysia (KKM) akan mengadakan sesi penerangan secara atas talian berkaitan status terkini Mekanisme Harga Ubat dan...
Kategori: Agenda | Tarikh: 24 Dec 2020
Protocol Medication Therapy Adherence Clinic-Cardiac Rehabilitation (CR-MTAC) 1ST Edition (Year 2020)
The CR-MTAC protocol aims to  assist pharmacists in initiating and conducting the activities of cardiac rehabilitation in a standardized manner across all Ministry of Health’s (MOH) hospitals/...
Kategori: Dokumen | Tarikh: 21 Dec 2020
Protocol Medication Therapy Adherence Clinic-Cardiac Rehabilitation (CR-MTAC) 1ST Edition (Year 2020)
Protokol CR-MTAC  boleh digunakan sebagai rujukan untuk semua pegawai farmasi semasa pelaksanaan  CR-MTAC untuk memastikan keseragamaan di semua fasiliti KKM. Ia mengandungi semua proses...
Kategori: Dokumen | Tarikh: 21 Dec 2020
Anticoagulation MTAC (AC-MTAC) Protocol 2nd Edition
Anticoagulation Medication Therapy Adherence Clinic (AC-MTAC) was formerly known as Warfarin MTAC (WMTAC). Due to the discovery of direct oral anticoagulants (DOACs) such as Dabigatran, Rivaroxaban...
Kategori: Dokumen | Tarikh: 21 Dec 2020

Pages